Patent · US Active

Megamonas funiformis and applications thereof

US11160837B2 · kind B2 · utility

1Cited by

0References

10Claims

0Family size

Assignee

BGI SHENZHEN · CN

Inventors

Yuanqiang Zou · Nanhu, CN
Liang Xiao · Lo Wu, CN
Xiaoping Li · Lo Wu, CN
Jinghong Yu · Lo Wu, CN
Chuan Liu · Lo Wu, CN

Key dates

Filing date	Sep 15, 2017
Grant date	Nov 2, 2021
Priority date	—
Expiry date	Sep 15, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12R2001/01
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are Megamonas funiformis and applications thereof. Specifically, the Megamonas funiformis has the effects for preventing and/or treating inflammation-related diseases, such as inflammatory bowel diseases (such as ulcerative enteritis, gastritis, and general enteritis) and cardiovascular diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.